UniCredit poszukuje partnera infrastrukturalnego do handlu i przechowywania kryptowalut: raport

Reuters, October 8 - On Thursday, reports indicated that the artificial intelligence company Firmus, supported by Nvidia (NVDA.O), is considering adjusting the terms of its highly touted 5 billions USD initial public offering (IPO), leading to a plunge in the stock price of Australia's Maas Group (MGH.AX) by as much as 30%. The stock fell to 4.47 AUD, marking its biggest intraday drop and the lowest point since May 6, causing the construction services company to lose around 483.37 millions USD (approximately 694 millions AUD) in market value. Here are more details: Maas holds a 3.2% stake in the data center operator, having earlier pledged, at the start of August, an additional injection of 300 millions AUD in both ordinary and preference shares priced at 230 AUD per share (link). Maas stated in an exchange announcement that speculation about whether the IPO would proceed as scheduled has put pressure on market sentiment, adding that it is not aware of any undisclosed information that could explain the situation. Firmus lists OpenAI as an anchor client and is currently preparing for the second largest IPO in Australian history (link). Earlier this week, reports suggested the company may lower the offering price from 11 AUD per share. If the listing is successfully completed, it will become Australia's largest IPO in nearly thirty years, second only to the 10 billions USD IPO of the country's biggest telecommunications operator, Telstra (TLS.AX), in 1997. Before Thursday’s stock plunge, Maas Group's shares had risen about 44% over the past 12 months, as investors valued its ties to AI-driven data center construction. Firmus has not immediately responded to Reuters’ request for comment. (1 USD = 1.4358 AUD) (For convenience, Reuters automatically translates its coverage into various languages. Automated translation may be inaccurate or lack required context; Reuters does not guarantee the accuracy of automatic translation and offers this feature only to assist readers. Reuters accepts no liability for any damages or losses caused by use of the automated translation feature.)

Według osób zaznajomionych ze sprawą, spółka zależna SK hynix (SKHY.US) zajmująca się pamięcią flash, Solidigm, wybrała banki prowadzące przyszłoroczne IPO w USA; emisją zajmują się Goldman Sachs oraz Morgan Stanley.

Pfizer (PFE.US) ogłosił w środę, że Amerykańska Agencja Żywności i Leków (FDA) zatwierdziła jego inhibitor kinazy tyrozynowej Tukysa (tucatinib) jako część skojarzonego schematu leczenia, do pierwszorzędowej terapii podtrzymującej dla określonego rodzaju raka piersi.